Regenerative Medical Technology Group Inc.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $29.2K |
| Cost of Revenue | $4.8K |
| Gross Profit | $24.4K |
| Gross Margin | 83.6% |
| Operating Expenses | |
| Research & Development | — |
| SG&A Expense | $92.0K |
| Operating Income | — |
| Operating Margin | — |
| Interest Expense | $383.7K |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-377.0K |
| Net Margin | -1,289.3% |
| EPS (Basic) | $-0.11 |
| EPS (Diluted) | $-0.11 |
| Shares Outstanding (Basic) | 3.7M |
| Shares Outstanding (Diluted) | 3.7M |
| Dividends Per Share | — |